Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 102-108

  Netherland, Courtney D ^a   Pickle, Theresa G ^a   Bales, Alicia ^a   Thewke, Douglas P ^a  

^a East Tennessee State University   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cannabinoid receptor 2; Collagen; Elastin; Macrophages; Matrix metalloproteinase 9; Smooth muscle cells

Indexed keywords

CANNABINOID; CANNABINOID 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CONTROLLED STUDY; HISTOLOGY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; ATHEROSCLEROSIS; DIET, ATHEROGENIC; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, SMOOTH MUSCLE; RECEPTOR, CANNABINOID, CB2; RECEPTORS, LDL;

EID: 77958495412     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.060     Document Type: Article

References (32)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
3. Liu J., Thewke D.P., Su Y.R., et al. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 2005, 25:174-179.
4. Arai S., Shelton J.M., Chen M., et al. A role for the apoptosis inhibitory factor aim/spalpha/api6 in atherosclerosis development. Cell Metab 2005, 1:201-213.
5. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ 2004, 11(Suppl. 1):S12-S16.
6. Matsuda L.A., Lolait S.J., Brownstein M.J., et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
7. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
8. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572.
9. Galiegue S., Mary S., Marchand J., et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232:54-61.
10. Buckley N.E., McCoy K.L., Mezey E., et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000, 396:141-149.
11. Mach F., Montecucco F., Steffens S. Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol 2008, 153:290-298.
12. Pacher P., Ungvari Z. Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases. Am J Physiol Heart Circ Physiol 2008, 294:H1133-H1134.
13. Montecucco F., Burger F., Mach F., et al. CB2 cannabinoid receptor agonist jwh-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 2008, 294:H1145-H1155.
14. Steffens S., Veillard N.R., Arnaud C., et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005, 434:782-786.
15. Freeman-Anderson N.E., Pickle T.G., Netherland C.D., et al. Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized ldl/oxysterol-induced apoptosis. J Lipid Res 2008, 49:2338-2346.
16. Sugamura K., Sugiyama S., Nozaki T., et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 2009, 119:28-36.
17. Zhao Y., Yuan Z., Liu Y., et al. Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 2010, (Epub ahead of print).
18. Paigen B., Morrow A., Holmes P.A., et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68:231-240.
19. Sukhova G.K., Shi G.P., Simon D.I., et al. Expression of the elastolytic cathepsins s and k in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583.
20. Freeman N.E., Rusinol A.E., Linton M., et al. Acyl-coenzyme a: cholesterol acyltransferase promotes oxidized ldl/oxysterol-induced apoptosis in macrophages. J Lipid Res 2005, 46:1933-1943.
21. Schmid P.C., Kuwae T., Krebsbach R.J., et al. Anandamide and other n-acylethanolamines in mouse peritoneal macrophages. Chem Phys Lipids 1997, 87:103-110.
22. Kuwae T., Shiota Y., Schmid P.C., et al. Biosynthesis and turnover of anandamide and other n-acylethanolamines in peritoneal macrophages. FEBS Lett 1999, 459:123-127.
23. Mackie K., Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. Aaps J 2006, 8:E298-306.
24. Begg M., Pacher P., Batkai S., et al. Evidence for novel cannabinoid receptors. Pharmacol Ther 2005, 106:133-145.
25. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
26. Rajesh M., Mukhopadhyay P., Hasko G., et al. CB2 cannabinoid receptor agonists attenuate tnf-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol 2008, 153:347-357.
27. Rajesh M., Mukhopadhyay P., Hasko G., et al. Cannabinoid cb1 receptor inhibition decreases vascular smooth muscle migration and proliferation. Biochem Biophys Res Commun 2008, 377:1248-1252.
28. Newby A.C., Zaltsman A.B. Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 1999, 41:345-360.
29. Newby A.C., Metalloproteinases vulnerable atherosclerotic plaques. Trends Cardiovasc Med 2007, 17:253-258.
30. Ghosh S., Preet A., Groopman J.E., et al. Cannabinoid receptor CB2 modulates the cxcl12/cxcr4-mediated chemotaxis of t lymphocytes. Mol Immunol 2006, 43:2169-2179.
31. Tauber S., Scheider-Stock R., Ullrich O. Investigating immunomodulatory mechanisms of cannabinoids: the role of mmp-9. Cell Commun Signal 2009, 7(Suppl. 1):A89.
32. Rosenfeld M.E., Polinsky P., Virmani R., et al. Advanced atherosclerotic lesions in the innominate artery of the apoe knockout mouse. Arterioscler Thromb Vasc Biol 2000, 20:2587-2592.